Kathleen Ann Creech
CIK 1971145 · View on SEC EDGAR ↗
First SEC filing: March 3, 2025 · Latest: March 3, 2025
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 1, 2025 | DBD | F | 849 | $44.23 | $37,551 | 15,134 Direct | -5.31% | Disposed | 53.9% (price as of 2026-08-21) |
| March 1, 2025 | DBD | A | 8,174 | — | — | 15,983 Direct | +104.67% | Acquired | (price as of 2026-08-21) |
| Sept. 15, 2024 | DBD | A | 7,809 | — | — | 7,809 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
DBD
Chief People Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | — | — | — | — | — | — | — | — |
| 2023 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.